Therapeutic area intelligence for Drug Delivery with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Advancements →

Enhanced →

Recent signals(2)

StrategyJuly 17, 2026

Enhanced intestinal delivery of volatile phytotherapeutics via self-microemulsifying systems

Developed solid self-microemulsifying drug delivery systems (SMEDDS) for improved intestinal absorption of phytotherapeutics.

StrategyJune 21, 2026

Advancements in Subcutaneous Drug Delivery for High Concentration Antibody Products

The review discusses the development of patient-centered subcutaneous drug delivery systems for high concentration biologics, emphasizing formulation and device options.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.